Jazz Pharmaceuticals (JAZZ) Tops Q3 EPS by $2.20, provides guidance
Go back to Jazz Pharmaceuticals (JAZZ) Tops Q3 EPS by $2.20, provides guidance| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 227.11 +1.19 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.92 | 52 Week High | $160.00 | |||
| Open | $225.27 | 52 Week Low | $95.80 | |||
| Day High | $227.17 | P/E | 42.21 | |||
| Day Low | $222.93 | EPS | $5.38 | |||
| Volume | 261,029 | |||||
